Clarkston Capital Partners LLC cut its stake in Clarivate PLC (NYSE:CLVT – Free Report) by 2.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 64,972,134 shares of the company’s stock after selling 1,736,304 shares during the period. Clarivate accounts for about 5.0% of Clarkston Capital Partners LLC’s investment portfolio, making the stock its 3rd biggest position. Clarkston Capital Partners LLC owned approximately 0.10% of Clarivate worth $217,007,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently modified their holdings of the stock. HRT Financial LP raised its stake in shares of Clarivate by 1,000.4% in the fourth quarter. HRT Financial LP now owns 1,043,745 shares of the company’s stock worth $3,486,000 after acquiring an additional 948,891 shares during the last quarter. Skba Capital Management LLC raised its stake in shares of Clarivate by 113.6% in the fourth quarter. Skba Capital Management LLC now owns 180,040 shares of the company’s stock worth $601,000 after acquiring an additional 95,760 shares during the last quarter. CIBC Private Wealth Group LLC raised its stake in shares of Clarivate by 77.3% in the fourth quarter. CIBC Private Wealth Group LLC now owns 507,981 shares of the company’s stock worth $1,697,000 after acquiring an additional 221,474 shares during the last quarter. Great Valley Advisor Group Inc. bought a new position in shares of Clarivate in the fourth quarter worth about $131,000. Finally, Nuveen LLC raised its stake in shares of Clarivate by 2.1% in the fourth quarter. Nuveen LLC now owns 977,269 shares of the company’s stock worth $3,264,000 after acquiring an additional 19,735 shares during the last quarter. 85.72% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have weighed in on CLVT shares. Royal Bank Of Canada dropped their target price on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a research note on Wednesday, February 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Barclays lowered their price target on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a research report on Wednesday, February 25th. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Citigroup lowered their price target on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a research report on Wednesday, March 4th. Five investment analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, Clarivate presently has an average rating of “Reduce” and an average price target of $3.22.
Clarivate Stock Up 0.3%
Shares of NYSE:CLVT opened at $2.21 on Friday. Clarivate PLC has a one year low of $1.66 and a one year high of $4.77. The company has a 50 day moving average of $2.52 and a 200-day moving average of $2.74. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84. The stock has a market cap of $1.41 billion, a price-to-earnings ratio of -10.50 and a beta of 1.36.
Clarivate (NYSE:CLVT – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company had revenue of $585.50 million during the quarter, compared to analysts’ expectations of $569.50 million. During the same quarter in the previous year, the company earned $0.14 EPS. Clarivate’s revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, sell-side analysts forecast that Clarivate PLC will post 0.65 earnings per share for the current year.
About Clarivate
Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.
Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.
Featured Stories
- Five stocks we like better than Clarivate
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate PLC (NYSE:CLVT – Free Report).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.
